Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;34(10):550-3.

Prescribing trends with levalbuterol (xopenex) at a community hospital

Nicole D Verkleeren, Krista M Lipchick

Prescribing trends with levalbuterol (xopenex) at a community hospital

Nicole D Verkleeren et al. P T. 2009 Oct.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Change in heart rate (HR) after breathing therapies with albuterol and levalbuterol (Xopenex). The graph shows the percentage of total therapies (n = 1,066) categorized by pre-treatment to post-treatment changes in HR. Nebulizations without pre-dose and post-dose HRs documented are excluded from the figure (i.e., 22.8% of albuterol therapies and 20.9% of levalbuterol therapies). bpm = beats/minute. For the last color key, there are zero data points (not represented).
See this image and copyright information in PMC

References

    1. Page CP, Morley J. Contrasting properties of albuterol stereo-isomers. J Allergy Clin Immunol. 1999;4(2):S31–S41. - PubMed
    1. Nelson HS. Beta-adrenergic bronchodilators. N Engl J Med. 1995;333:499–506. - PubMed
    1. Handley D.The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists J Allergy Clin Immunol 1999104(2, Part 2):S69–S76. - PubMed
    1. Perrin-Fayolle M, Blum PS, Morley J, et al. Differential responses of asthmatic airways to enantiomers of albuterol: Implications for clinical treatment of asthma. Clin Rev Allergy Immunol. 1996;14:139–147. - PubMed
    1. Lam S, Chen J. Changes in heart rate associated with nebulized racemic albuterol and levalbuterol in intensive care patients. Am J Health Syst Pharm. 2003;60:1971–1975. - PubMed

LinkOut - more resources